Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1600 1618 1632 1645 1647 1654 1681 4111
This examiner grants 25% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18361179 | ANTI-GARP-TGF-BETA1/PD-1 COMBINATION THERAPY | Non-Final OA | AbbVie Deutschland GmbH & Co. KG |
| 18294767 | METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18042989 | METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18854288 | HUMAN IGE MONOCLONAL ANTIBODIES TO PARASITIC WORM ANTIGENS AND USES THEREFOR | Non-Final OA | Vanderbilt University |
| 18123112 | CAR CELLS TARGETING AN INSERTED LIGAND | Final Rejection | Massachusetts Institute of Technology |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy